Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes. Diabetes Care 2018;41:e150-e151.
作者信息
Jørgensen Line Bisgaard, Yderstræde Knud
机构信息
Steno Diabetes Center Odense, Odense University Hospital and Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
Steno Diabetes Center Odense, Odense University Hospital and Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
出版信息
Diabetes Care. 2019 May;42(5):e77. doi: 10.2337/dc18-2595.
PMID:31010946
Abstract
摘要
相似文献
1
Comment on Wright et al. Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes. Diabetes Care 2018;41:e150-e151.对赖特等人的评论。免疫检查点抑制剂相关糖尿病报告增加。《糖尿病护理》2018年；41:e150 - e151。
Diabetes Care. 2019 May;42(5):e77. doi: 10.2337/dc18-2595.
2
Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154.对Trinh等人的评论。英夫利昔单抗成功治疗免疫检查点抑制剂诱导的糖尿病。《糖尿病护理》2019年；42:e153 - e154。
Diabetes Care. 2020 Jan;43(1):e10. doi: 10.2337/dc19-1747.
3
Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154.对关于Trinh等人的评论的回复。英夫利昔单抗成功治疗免疫检查点抑制剂诱导的糖尿病。《糖尿病护理》2019年；42:e153 - e154。
Diabetes Care. 2020 Jan;43(1):e11. doi: 10.2337/dci19-0058.
4
Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.对关于费兰尼尼等人《糖尿病护理》2016年；39:1108 - 1114的评论。对穆达利亚尔等人《糖尿病护理》2016年；39:1115 - 1122的评论。
Diabetes Care. 2016 Nov;39(11):e196-e197. doi: 10.2337/dci16-0027.
5
Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.对拉塞尔 - 琼斯等人的评论。《糖尿病护理》2017年；40:943 - 950。对鲍林等人的评论。《糖尿病护理》2017年；40:951 - 957。
Diabetes Care. 2018 Mar;41(3):e27-e28. doi: 10.2337/dc17-1916.
6
Response to Comment on Russell-Jones et al. Diabetes Care 2017;40:943-950. Comment on Bowering et al. Diabetes Care 2017;40:951-957.对关于拉塞尔 - 琼斯等人的评论的回应。《糖尿病护理》2017年；40:943 - 950。对鲍林等人的评论。《糖尿病护理》2017年；40:951 - 957。
Diabetes Care. 2018 Mar;41(3):e29-e30. doi: 10.2337/dci17-0051.
7
Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.对费兰尼尼等人的评论。《糖尿病护理》2016年；39:1108 - 1114。对穆达利亚尔等人的评论。《糖尿病护理》2016年；39:1115 - 1122。
Diabetes Care. 2016 Nov;39(11):e195. doi: 10.2337/dc16-1332.
8
Appropriately reporting results using the medication subscale of the summary of diabetes self-care activities measure: A comment on Dasappa . (2017).使用糖尿病自我护理活动总结量表的药物治疗分量表恰当地报告结果：对达萨帕的评论。（2017年）
J Family Med Prim Care. 2018 May-Jun;7(3):645-646. doi: 10.4103/jfmpc.jfmpc_345_17.
9
Kinetic, spectroscopic, and X-ray crystallographic characterization of the functional E151H aminopeptidase from Aeromonas proteolytica.解蛋白气单胞菌功能性E151H氨肽酶的动力学、光谱学及X射线晶体学表征
Biochemistry. 2005 Sep 13;44(36):12030-40. doi: 10.1021/bi0505823.
10
Systemic vasculitis developed after immune checkpoint inhibition: comment on the article by Cappelli et al.
Arthritis Care Res (Hoboken). 2018 Aug;70(8):1275. doi: 10.1002/acr.23481.
Zotero 插件